Azothioformamide small molecules and metal complexes for bioactivity applications
A novel class of redox-active small molecule ligands, azothioformamides, closely related to pharmacologic thiosemicarbazones, synthesized via a straightforward one-pot four-step process. A series of metal complexes have been produced in high yields, with unpublished preliminary bioactivity data suggesting potential applications in pharmaceutical and bioinorganic research.
Overview
Azothioformamides are a small molecule, redox-active ligand class closely related to the well-known pharmacologic thiosemicarbazones and their metal complexes. This research program focuses on developing a versatile library of these compounds along with their metal coordination complexes for potential bioactivity applications. The approach is designed to be accessible, scalable, and amenable to generating multiple structural variations, making it attractive for partners interested in medicinal chemistry, bioinorganic chemistry, or drug discovery exploration. Unpublished preliminary bioactivity data suggests promising directions that warrant further investigation and partnership.
Technical specifications
Synthesis approach:
- One-pot, four-step synthesis route designed for efficiency and accessibility
- Ethanol-based solvent system followed by a neat reflux reaction
- Recrystallization identified as a viable purification alternative to current chromatographic methods
Key features:
- High yields achieved across a series of synthesized compounds
- Straightforward access to multiple structural variations and analogs
- Ease of forming metal complexes, enabling exploration of bioinorganic applications
- Structural similarity to thiosemicarbazones, a class with established pharmacological relevance
Technology readiness level
The synthesis methodology has been demonstrated in the laboratory with a series of compounds and metal complexes successfully produced in high yields. Unpublished preliminary bioactivity data exists, indicating early-stage validation of the platform's potential. Further bioactivity screening and optimization studies are needed to advance the compounds toward specific therapeutic or commercial applications. The technology is currently at an early research stage with opportunities for collaborative development, sponsored research, and co-development partnerships to advance the science toward practical applications.
About University of Idaho
Founded as Idaho’s land‑grant, the University of Idaho is a comprehensive public research university with a statewide footprint anchored in Moscow. Industry engages through a Post Falls research park that co‑locates companies with faculty, multi‑campus centers in Boise, Coeur d’Alene and Idaho Falls, and an Extension network active in 42 counties. Proximity and formal agreements with Idaho National Laboratory provide a direct conduit to national‑lab expertise and shared facilities in Idaho Falls. Research is backed by competitive federal funding from agencies such as the National Science Foundation, U.S. Department of Agriculture and the Department of Energy. A dedicated technology transfer office supports IP strategy, licensing and startup formation.
delivered to your inbox.